Literature DB >> 3604579

Differentiation in the medulloblastoma. A histological and immunohistochemical study.

P C Burger, F C Grahmann, A Bliestle, P Kleihues.   

Abstract

The histological and immunohistological features of medulloblastomas were investigated in patients participating in an ongoing cooperative study of the Societé International d'Oncologie Pédiatrique (SIOP). Of 51 neoplasms, four were the classic desmoplastic variant. In regard to the histological features used to grade neoplasms, considerable inter- and intratumoral variation was observed. The neoplasms with the most pleomorphic and coarsely structured nuclei tended to be neuroblastic, whereas the most delicate and uniform nuclei were found in the desmoplastic neoplasms. Twenty-one of the cases exhibited neuroblastic differentiation in the form of neuroblastic rosettes. Of these, three also contained neoplastic ganglion cells. Of the five medulloblastomas that were calcified, four contained neuroblastic rosettes in accord with the tendency for calcification in neuroblastic neoplasms. In many of the neuroblastic neoplasms, islands of markedly neuron-specific enolase (NSE)-positive cells were seen. Although the limited specificity of this marker enzyme is recognized, we believe that this focal intense staining could indicate neuronal differentiation somewhat more advanced than in small NSE-positive islands of reduced cellularity, many of which were strongly positive. The nuclei in these island were usually larger and more vesicular than those in the surrounding densely cellular areas. These features and the frequent association with Homer-Wright rosettes suggest that these foci represent a form of neuronal differentiation. Astrocytic differentiation was more difficult to define and required the use of staining for glial fibrillary acidic protein (GFAP). Six neoplasms contained GFAP-positive cells that were clearly neoplastic. Many others contained scattered reactive astrocytes and dispersed cells whose neoplastic versus reactive nature could not be defined.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3604579     DOI: 10.1007/bf00693776

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  29 in total

1.  THE MEDULLOBLASTOMA AND THE SO-CALLED "ARACHNOIDAL CEREBELLAR SARCOMA".

Authors:  L J RUBINSTEIN; D W NORTHFIELD
Journal:  Brain       Date:  1964-06       Impact factor: 13.501

2.  The treatment and prognosis of medulloblastoma in children. A study of 82 verified cases.

Authors:  H J Bloom; E N Wallace; J M Henk
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1969-01

3.  Central neurocytoma. An electron-microscopic study of two cases.

Authors:  J Hassoun; D Gambarelli; F Grisoli; W Pellet; G Salamon; J F Pellissier; M Toga
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

4.  Differentiation of Medulloblastoma. Studies including immunohistochemical localization of glial fibrillary acidic protein.

Authors:  J O Palmer; A G Kasselberg; M G Netsky
Journal:  J Neurosurg       Date:  1981-08       Impact factor: 5.115

5.  Immunohistochemical localization of gamma-enolase in normal human tissues other than nervous and neuroendocrine tissues.

Authors:  H Haimoto; Y Takahashi; T Koshikawa; H Nagura; K Kato
Journal:  Lab Invest       Date:  1985-03       Impact factor: 5.662

6.  The cerebellar medulloblastoma and its relationship to primitive neuroectodermal tumors.

Authors:  L B Rorke
Journal:  J Neuropathol Exp Neurol       Date:  1983-01       Impact factor: 3.685

7.  Neuronal and astrocytic differentiation in human neuroepithelial neoplasms. An immunohistochemical study.

Authors:  U Roessmann; M E Velasco; P Gambetti; L Autilio-Gambetti
Journal:  J Neuropathol Exp Neurol       Date:  1983-03       Impact factor: 3.685

8.  Glial fibrillary acidic protein in medulloblastoma.

Authors:  H Mannoji; I Takeshita; M Fukui; M Ohta; K Kitamura
Journal:  Acta Neuropathol       Date:  1981       Impact factor: 17.088

9.  Medulloblastoma. Results of a sequential combined treatment.

Authors:  F F Bellani; M Gasparini; F Lombardi; R Zucali; G Luccarelli; F Migliavacca; S Moise; G Nicola
Journal:  Cancer       Date:  1984-11-01       Impact factor: 6.860

10.  Medulloblastoma. The identification of prognostic subgroups and implications for multimodality management.

Authors:  G Kopelson; R M Linggood; G M Kleinman
Journal:  Cancer       Date:  1983-01-15       Impact factor: 6.860

View more
  31 in total

1.  Differentiation in medulloblastomas: correlation between the immunocytochemical demonstration of photoreceptor markers (S-antigen, rod-opsin) and the survival rate in 66 patients.

Authors:  M Czerwionka; H W Korf; O Hoffmann; H Busch; W Schachenmayr
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

Review 2.  Neuropathology for the neuroradiologist: rosettes and pseudorosettes.

Authors:  F J Wippold; A Perry
Journal:  AJNR Am J Neuroradiol       Date:  2006-03       Impact factor: 3.825

Review 3.  Childhood medulloblastoma: current status of biology and treatment.

Authors:  Laura J Klesse; Daniel C Bowers
Journal:  CNS Drugs       Date:  2010-04       Impact factor: 5.749

4.  Immunohistochemistry of primitive neuroectodermal tumors in infants with special emphasis on cytokeratin expression.

Authors:  T Grieshammer; C Zimmer; K T Vogeley
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

5.  Embryonal central nervous system neoplasms arising in infants and young children: a pediatric brain tumor consortium study.

Authors:  Roger E McLendon; Adesina Adekunle; Veena Rajaram; Mehmet Koçak; Susan M Blaney
Journal:  Arch Pathol Lab Med       Date:  2011-08       Impact factor: 5.534

6.  Patterns of differentiation in central neurocytoma. An immunohistochemical study of eleven biopsies.

Authors:  A von Deimling; R Janzer; P Kleihues; O D Wiestler
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  Immunohistochemical characterization of primitive neuroectodermal tumors and their possible relationship to the stepwise ontogenetic development of the central nervous system. 2. Tumor studies.

Authors:  R Kleinert
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

8.  Age-related immunoreactivity pattern in medulloblastoma.

Authors:  S Patt; C Zimmer
Journal:  Childs Nerv Syst       Date:  1992-09       Impact factor: 1.475

9.  Melanotic medulloblastoma. A case report with immunohistochemical and ultrastructural examination.

Authors:  C L Dolman
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

10.  "Desmoplastic" versus "classic" medulloblastoma: comparison of DNA content, histopathology and differentiation.

Authors:  F Giangaspero; P Chieco; C Ceccarelli; G Lisignoli; R Pozzuoli; M Gambacorta; G Rossi; P C Burger
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.